Would You Know Where Your Peptides Came From?
Newsletter issue · 2026-10-15
A circulating investigation has put peptide sourcing in the spotlight. What the label cannot tell you — and the five sourcing questions every patient deserves to have answered.
By Wellness Lab.

A circulating investigation has put peptide sourcing in the spotlight. Here is what the label cannot tell you, and why the source deserves your attention. Two vials can carry the same peptide name and still differ in sourcing, preparation, concentration, storage, labeling, and intended use. That is why choosing a peptide should never begin with the label alone. It should begin with a clear source, an appropriate clinical evaluation, and someone accountable for your care.
What the report does and does not establish
The reports have not been independently verified, they do not prove that retatrutide — or whatever was actually in the vials — caused either death, and the FDA did not confirm the products' contents. CBS reports do not establish causation.
What the report does reinforce: a peptide name on a label cannot replace verified identity, traceable sourcing, proper handling, individualized clinical evaluation, and ongoing guidance. Retatrutide is not FDA-approved, and products labeled for research use are not medications intended for patient treatment.
Three common categories: know the pathway
Grey market, outside licensed channels: grey market is an informal term for products sold through channels outside the normal licensed prescription, pharmacy, or authorized distribution pathway. The origin and handling may be difficult to verify.
Research use, for laboratory research: products labeled research use only or not for human consumption are not intended as medications for patient treatment. Research products are often sold through grey market channels, so these categories can overlap.
Prescription compounded, prepared for patient care: prepared after a licensed clinician's evaluation and prescription by a properly licensed compounding pharmacy under applicable requirements, with a dispensing record and a care pathway.
An important distinction: know the approval status
Compounded medications may serve an important clinical need, but they are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. A prescription and licensed pharmacy create a more accountable medical pathway — not a claim of FDA approval.
The FDA states that retatrutide cannot be used in compounding under federal law. This general background about compounding does not establish a lawful retatrutide treatment pathway, and no claim is made here that retatrutide is available or offered. Retatrutide is not FDA-approved and has not been found safe or effective for any condition.
Why sourcing matters: more than a name
A responsible sourcing conversation should make room for five basic questions. Ingredient identity: is the product what the label says it is? Concentration: does the prepared strength match the prescription and label?
Preparation controls: what standards support cleanliness, sterility when required, and consistency? Storage and handling: was the product protected during preparation, shipping, and storage? Traceability: can the dispensing pharmacy, prescription, lot information, and patient record be identified?
The value of clinical oversight: why a provider matters
Choosing a peptide begins with understanding your health, medications, goals, and whether treatment is appropriate for you. A provider reviews your medical history, current medications, symptoms, and goals; determines whether treatment is appropriate and discusses relevant alternatives, benefits, and risks; identifies the pharmacy preparing and dispensing the prescription; provides clear, patient-specific instructions for use, storage, and administration; and follows your response, answers questions, and adjusts or stops the plan when clinically appropriate.
Buying a vial is not the same as receiving medical care.
Before you begin: five questions to ask
Is this product intended for human use — or labeled for research only? Who evaluated me and prescribed it? Which licensed pharmacy prepared and dispensed it? What are the exact concentration, storage instructions, and beyond-use date? Who can I contact if I have a question or concern?
“You should understand what you are receiving, why it was selected, where it came from, and who is available if you have questions. My role is not simply to recommend a product. It is to evaluate the whole picture, create a plan that fits you, and stay involved as your care continues.”
Clinical references
- CBS News: Two Deaths Reported After Use of Products Claiming to Be Retatrutide — https://www.cbsnews.com/news/deaths-reported-fda-bootleg-reta-weight-loss-drug/
- FDA: Concerns With Unapproved GLP-1 Drugs and Research Use Products — https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- FDA: Compounding and the FDA — Questions and Answers — https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA: Human Drug Compounding — https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
- FDA: How to Buy Medicines Safely From an Online Pharmacy — https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy
- FDA: 2026 Warning Letter Addressing Research Use Only Peptide Marketing
- USP: Quality Standards for Compounding
Key takeaways
- A peptide name on a label cannot replace verified identity, traceable sourcing, proper handling, individualized clinical evaluation, and ongoing guidance.
- Grey market and research-use-only products are not medications intended for patient treatment; the CBS reports do not establish causation.
- Compounded medications are not FDA-approved; the FDA states retatrutide cannot be used in compounding under federal law, and this background does not establish a lawful retatrutide pathway.
- Ask five sourcing questions: human use vs. research, who prescribed, which licensed pharmacy, concentration and storage, and who to contact.
- Buying a vial is not the same as receiving medical care.
General education, not individualized medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved, and FDA does not review safety, effectiveness, or quality before marketing. Appropriateness depends on the individual, product, pharmacy, applicable law, and clinician judgment. Do not use research-only or not-for-human-consumption products as patient treatments. For personal treatment questions, book a consultation. For current symptoms or medication safety, contact the Care Line.
Have a non-urgent personal question? Book a Wellness Lab visit to discuss your care with Danielle Johnson, FNP-C.
Book a Wellness Lab visitText Care Line at (512) 856-9612 for routine refill, order, or portal administration and current medication-safety questions.
Related Wellness Lab articles

World Mental Health Day: A Calmer Mind, A Clearer Day, And The Limits Of Peptide Research
World Mental Health Day is a reminder that mental health is health. Selank and Semax have been studied in limited human research, but the evidence base remains limited and clinical benefit is not established — they are not a substitute for psychiatric care.

The September Skin Brief: SNAP-8 And GHK-Cu For Expression Lines And Skin Quality
SNAP-8 is a topical cosmetic peptide used in formulas for expression-prone areas, and it may pair with GHK-Cu when the conversation is smoother-looking skin and a more polished routine. Two peptides, two different roles.

The Biology Of Skin, Hair & Repair: Collagen, Inflammation, Gut & The Hair Cycle
Collagen, inflammatory signaling, the gut environment, and the hair-growth cycle are not separate conversations. Repair is a sequence: communicate, regulate, rebuild, remodel.